|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12.12.25 - 00:57
|
FedEx Aktie: Margenpotenzial bei RemainCo & SpinCo - 2026 als Triggerjahr? (Aktiencheck)
|
|
|
New York (www.aktiencheck.de) - FedEx-Aktienanalyse von Jefferies & Co:
Die Analysten von Jefferies & Co empfehlen die Aktie von FedEx Corporation (ISIN: US31428X1063, WKN: 912029, Ticker-Symbol: FDX, NYSE-Symbol: FDX) weiterhin zum Kauf.
Die Aktie sei in den vergangenen drei Monaten um 23% gestiegen, angetrieben durch starkes US-Wachstum und einen anhaltenden Fokus auf Umsatzqualität und Kosteneffizienz, merke Jefferies an, der "erfreut über das starke Momentum" sei und für 2026 Katalysatoren durch den kommenden LTL-Spin sehe. [mehr]...
|
|
|
|
|
10.12.25 - 17:30
|
GXP-Storage Appoints FedEx Healthcare & Life Sciences President Nick Gennari to Board of Directors (Business Wire)
|
|
|
Global logistics executive brings three decades of supply-chain leadership to advance unified visibility in regulated material management
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--GXP-Storage®, a life sciences leader in compliant, visible, and scalable material management, announced today the appointment of Nick Gennari, President of Global Healthcare & Life Sciences, Healthcare and Commercial Sales at FedEx, as an Independent Board Member, effective November 20, 2025.
With more than 30 years of global logistics and supply-chain leadership, Gennari brings deep expertise in healthcare transportation, cold-chain management and quality-controlled delivery. His appointment reflects GXP-Storage's commitment to integrating storage and logistics to deliver complete lifecycle visibility—from materials in transit to those at rest.
“The life sciences industry has long treated storage and logistics as separate functions,” said Jeff Johnson, Founder and CEO of GXP-Storage. “Nick's appointment represen...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
